suprachoroidal CLS-TA: Clinical Trials

2 terminated. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Terminated 2

Follow suprachoroidal CLS-TA: new trials by email Literature Review of suprachoroidal CLS-TA trials Research Report on suprachoroidal CLS-TA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin - Macular Edema, Retinal Vein Occlusion	Phase 3	Terminated	Clearside Biomedical, Inc.	325	2018-03-05	2021-04-23
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept - Macular Edema, Retinal Vein Occlusion	Phase 3	Terminated	Clearside Biomedical, Inc.	460	2017-01-31	2021-04-14

Conditions studied

Macular Edema (2)  ·  Retinal Vein Occlusion (2)

Sponsors

Clearside Biomedical, Inc. (2)

Countries

Australia (2)  ·  Hungary (2)  ·  India (2)  ·  United States (2)  ·  Austria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Israel (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Philippines (1)  ·  Poland (1)  ·  Portugal (1)  ·  Slovakia (1)  ·  Spain (1)

Top investigators

Thomas Ciulla, MD (1)  ·  Thomas Ciulla, MD MBA (1)